Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301)
暂无分享,去创建一个
E. Oki | F. Fujita | H. Saeki | Y. Akagi | K. Ando | H. Baba | K. Ihara | G. Nakayama | M. Shimokawa | M. Tominaga | S. Mori | M. Mori | K. Miwa | M. Enomoto